AKTX
Akari Therapeutics PLC · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$3.63+$0.09 (+2.54%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for AKTX is being prepared.
Key Stats
Key Stats
Open
$3.43
Day High
$3.63
Day Low
$3.29
Prev Close
$3.54
Volume
0
Avg Volume
44.7K
Day Change
+$0.09
Change %
+2.54%
Fundamentals
Fundamentals
P/B
0.31
EPS (TTM)
$-0.01
Market Cap
$5M
52-Wk Range
$3.25 — $63.20
Who Owns This Stock
Who Owns AKTX
Other99.3%18 holders
Dealer / Bank0.7%3 holders
Based on Q4 2025 13F filings + AC behavioral model
21 institutional holders
Top Holders
$787.2B
0.0%$237.7B
$88.7B
$42.2B
0.0%$22.9B
$20.0B
$19.5B
$15.9B
$14.2B
0.0%$6.8B
$6.3B
$6.2B
$5.9B
+56.8%$4.9B
$3.2B
$2.0B
-50.0%$1.4B
$1.2B
+73.3%$75M
$58M
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Mild Selling Pressure
Other(99.3%)
●
—Dealer / Bank(0.7%)
●
FacilitatingUpdated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus9 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows17 increased/new, 2 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of AKTX on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.